Q3 2026 13F filing
Updated 9 days ago79 disclosed positions worth $173.1M
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | K KLA CORPORATION | $32.5M | 166.9K | 18.80% | — |
| 2 | C BRISTOL-MYERS SQUIBB CO | $14M | 224.2K | 8.08% | — |
| 3 | L LAM RESEARCH CORPORATION | $9.9M | 30.0K | 5.69% | — |
| 4 | B BIODESIX INC | $8.6M | 286.8K | 4.94% | — |
| 5 | C CORCEPT THERAPEUTICS INC | $6.4M | 55.2K | 3.67% | — |
| 6 | O OVINTIV INC | $6.2M | 107.5K | 3.59% | — |
| 7 | R ULTRAGENYX PHARMACEUTICAL INC | $5.6M | 373.7K | 3.24% | — |
| 8 | S SOLID BIOSCIENCES INC | $5.2M | 716.0K | 2.99% | — |
| 9 | P PROTAGONIST THERAPEUTICS INC | $4.9M | 35.0K | 2.85% | — |
| 10 | P PROTHENA CORP PLC | $3.8M | 449.0K | 2.17% | — |
| 11 | H HALOZYME THERAPEUTICS INC | $3.7M | 33.4K | 2.13% | — |
| 12 | S STOKE THERAPEUTICS INC | $3.6M | 138.0K | 2.07% | — |
| 13 | N NEUROCRINE BIOSCIENCES INC | $3.6M | 25.2K | 2.06% | — |
| 14 | A ACADIA PHARMACEUTICALS INC | $3.4M | 171.0K | 1.99% | — |
| 15 | N INTELLIA THERAPEUTICS INC | $3.4M | 281.4K | 1.96% | — |
| 16 | N NEKTAR THERAPEUTICS | $2.8M | 46.0K | 1.61% | — |
| 17 | V VIR BIOTECHNOLOGY INC | $2.5M | 227.0K | 1.47% | — |
| 18 | Z ZENAS BIOPHARMA INC | $2.5M | 93.4K | 1.45% | — |
| 19 | ? N/A CONTINEUM THERAPEUTICS INC (CTNM) P @ 15.0 01/15/2027 | $2.3M | 3.5K | 1.31% | — |
| 20 | A ABIVAX SA | $2.1M | 21.0K | 1.20% | — |
| 21 | B BIOGEN INC | $2M | 9.0K | 1.17% | — |
| 22 | A ALKERMES PLC | $2M | 50.0K | 1.17% | — |
| 23 | D DEFINIUM THERAPEUTICS INC | $2M | 52.0K | 1.14% | — |
| 24 | C CYTOKINETICS INC | $2M | 30.0K | 1.14% | — |
| 25 | C CELLDEX THERAPEUTICS INC | $1.9M | 57.2K | 1.07% | — |
| 26 | E EQT CORPORATION | $1.7M | 34.6K | 0.97% | — |
| 27 | ? N/A COMPASS THERAPEUTICS INC | $1.6M | 1.57M | 0.95% | — |
| 28 | X XENON PHARMACEUTICALS INC | $1.6M | 43.0K | 0.92% | — |
| 29 | R RELMADA THERAPEUTICS INC | $1.5M | 408.1K | 0.89% | — |
| 30 | T TRAVERE THERAPEUTICS INC | $1.5M | 25.0K | 0.85% | — |
| 31 | A ADAGENE INC | $1.4M | 430.0K | 0.79% | — |
| 32 | U UNITED THERAPEUTICS CORP | $1.4M | 2.5K | 0.78% | — |
| 33 | F FREEPORT-MCMORAN CL-B | $1.3M | 18.0K | 0.73% | — |
| 34 | I QUINCE THERAPEUTICS INC | $1.3M | 40.6K | 0.73% | — |
| 35 | V VALNEVA SE | $1.2M | 201.4K | 0.72% | — |
| 36 | B BRIDGEBIO PHARMA INC | $1.2M | 18.7K | 0.71% | — |
| 37 | I IMMUNOME INC | $1.2M | 55.6K | 0.69% | — |
| 38 | A AXSOME THERAPEUTICS INC | $1.1M | 6.0K | 0.64% | — |
| 39 | ? N/A ANNEXON INC (ANNX) P @ 5.0 01/15/2027 | $1M | 4.4K | 0.61% | — |
| 40 | J JATT II ACQUISITION CORP | $1M | 90.5K | 0.59% | — |
| 41 | F FOGHORN THERAPEUTICS INC | $1M | 282.3K | 0.58% | — |
| 42 | P PHARVARIS N V | $947K | 29.8K | 0.55% | — |
| 43 | Q QUIDELORTHO CORP | $942K | 89.4K | 0.54% | — |
| 44 | ? N/A BLOSSOMHILL THERAPEUTICS INC | $932K | 50.0K | 0.54% | — |
| 45 | ? N/A DISC MEDICINE INC (IRON) P @ 80.0 01/15/2027 | $842K | 450 | 0.49% | — |
| 46 | C CASTLE BIOSCIENCES INC | $815K | 22.9K | 0.47% | — |
| 47 | D BRIGHT MINDS BIOSCIENCES INC | $767K | 15.4K | 0.44% | — |
| 48 | H HARROW HEALTH INC | $739K | 24.0K | 0.43% | — |
| 49 | B BICYCLE THERAPEUTICS PLC | $649K | 176.4K | 0.38% | — |
| 50 | ? N/A VOYAGER THERAPEUTICS INC | $603K | 224.9K | 0.35% | — |